Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

AIB1 and its significant role in tumor pathogenesis in systemic malignancies: beyond breast carcinomas.

Kapoor S.

Ann Oncol. 2013 May;24(5):1414. doi: 10.1093/annonc/mdt060. Epub 2013 Feb 27. No abstract available.

PMID:
23446091
[PubMed - indexed for MEDLINE]
Free Article
2.

Regarding the letter to the editor 'AIB1 and its significant role in tumor pathogenesis in systemic malignancies: beyond breast carcinomas' by Kapoor and Shailendra in Annals of Oncology.

Alkner S.

Ann Oncol. 2013 May;24(5):1414-5. doi: 10.1093/annonc/mdt061. Epub 2013 Feb 21. No abstract available.

PMID:
23436911
[PubMed - indexed for MEDLINE]
Free Article
3.

The role of AIB1 and PAX2 in primary breast cancer: validation of AIB1 as a negative prognostic factor.

Alkner S, Bendahl P, Grabau D, Malmström P, Fernö M, Rydén L; South Swedish Breast Cancer Group.

Ann Oncol. 2013 May;24(5):1244-52. doi: 10.1093/annonc/mds613. Epub 2012 Dec 9.

PMID:
23230135
[PubMed - indexed for MEDLINE]
Free Article
4.

AIB1:ERα transcriptional activity is selectively enhanced in aromatase inhibitor-resistant breast cancer cells.

O'Hara J, Vareslija D, McBryan J, Bane F, Tibbitts P, Byrne C, Conroy RM, Hao Y, Gaora PÓ, Hill AD, McIlroy M, Young LS.

Clin Cancer Res. 2012 Jun 15;18(12):3305-15. doi: 10.1158/1078-0432.CCR-11-3300. Epub 2012 May 1.

PMID:
22550166
[PubMed - indexed for MEDLINE]
Free Article
5.

Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer.

Burandt E, Jens G, Holst F, Jänicke F, Müller V, Quaas A, Choschzick M, Wilczak W, Terracciano L, Simon R, Sauter G, Lebeau A.

Breast Cancer Res Treat. 2013 Feb;137(3):745-53. doi: 10.1007/s10549-013-2406-4. Epub 2013 Jan 16.

PMID:
23322234
[PubMed - indexed for MEDLINE]
6.

Effect of low-dose tamoxifen on steroid receptor coactivator 3/amplified in breast cancer 1 in normal and malignant human breast tissue.

Haugan Moi LL, Hauglid Flågeng M, Gandini S, Guerrieri-Gonzaga A, Bonanni B, Lazzeroni M, Gjerde J, Lien EA, DeCensi A, Mellgren G.

Clin Cancer Res. 2010 Apr 1;16(7):2176-86. doi: 10.1158/1078-0432.CCR-09-1859. Epub 2010 Mar 23. Erratum in: Clin Cancer Res. 2010 Oct 15;16(20):5087. De Censi, Andrea [corrected to DeCensi, Andrea].

PMID:
20332317
[PubMed - indexed for MEDLINE]
Free Article
7.

Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer.

Osborne CK, Bardou V, Hopp TA, Chamness GC, Hilsenbeck SG, Fuqua SA, Wong J, Allred DC, Clark GM, Schiff R.

J Natl Cancer Inst. 2003 Mar 5;95(5):353-61.

PMID:
12618500
[PubMed - indexed for MEDLINE]
Free Article
8.

Expression of AIB1 protein as a prognostic factor in breast cancer.

Lee K, Lee A, Song BJ, Kang CS.

World J Surg Oncol. 2011 Oct 29;9:139. doi: 10.1186/1477-7819-9-139.

PMID:
22035181
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Amplified in breast cancer 1 in human epidermal growth factor receptor - positive tumors of tamoxifen-treated breast cancer patients.

Kirkegaard T, McGlynn LM, Campbell FM, Müller S, Tovey SM, Dunne B, Nielsen KV, Cooke TG, Bartlett JM.

Clin Cancer Res. 2007 Mar 1;13(5):1405-11.

PMID:
17332282
[PubMed - indexed for MEDLINE]
Free Article
10.

Expression of the nuclear coactivator AIB1 in normal and malignant breast tissue.

List HJ, Reiter R, Singh B, Wellstein A, Riegel AT.

Breast Cancer Res Treat. 2001 Jul;68(1):21-8.

PMID:
11678305
[PubMed - indexed for MEDLINE]
11.

AIB1 is a predictive factor for tamoxifen response in premenopausal women.

Alkner S, Bendahl PO, Grabau D, Lövgren K, Stål O, Rydén L, Fernö M; Swedish and South-East Swedish Breast Cancer Groups.

Ann Oncol. 2010 Feb;21(2):238-44. doi: 10.1093/annonc/mdp293. Epub 2009 Jul 23.

PMID:
19628566
[PubMed - indexed for MEDLINE]
Free Article
12.

The nuclear receptor coactivator AIB1 mediates insulin-like growth factor I-induced phenotypic changes in human breast cancer cells.

Oh A, List HJ, Reiter R, Mani A, Zhang Y, Gehan E, Wellstein A, Riegel AT.

Cancer Res. 2004 Nov 15;64(22):8299-308.

PMID:
15548698
[PubMed - indexed for MEDLINE]
Free Article
13.

Role of AIB1 for tamoxifen resistance in estrogen receptor-positive breast cancer cells.

Su Q, Hu S, Gao H, Ma R, Yang Q, Pan Z, Wang T, Li F.

Oncology. 2008;75(3-4):159-68. doi: 10.1159/000159267. Epub 2008 Oct 1.

PMID:
18827493
[PubMed - indexed for MEDLINE]
14.

Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen.

Hurtado A, Holmes KA, Geistlinger TR, Hutcheson IR, Nicholson RI, Brown M, Jiang J, Howat WJ, Ali S, Carroll JS.

Nature. 2008 Dec 4;456(7222):663-6. doi: 10.1038/nature07483. Epub 2008 Nov 12. Erratum in: Nature. 2009 Feb 26;457(7233):1168.

PMID:
19005469
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

A role for TGF-beta in estrogen and retinoid mediated regulation of the nuclear receptor coactivator AIB1 in MCF-7 breast cancer cells.

Lauritsen KJ, List HJ, Reiter R, Wellstein A, Riegel AT.

Oncogene. 2002 Oct 17;21(47):7147-55.

PMID:
12370804
[PubMed - indexed for MEDLINE]
Free Article
16.

PTEN suppresses the oncogenic function of AIB1 through decreasing its protein stability via mechanism involving Fbw7 alpha.

Yang C, Li S, Wang M, Chang AK, Liu Y, Zhao F, Xiao L, Han L, Wang D, Li S, Wu H.

Mol Cancer. 2013 Mar 21;12:21. doi: 10.1186/1476-4598-12-21.

PMID:
23514585
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Ribozyme targeting demonstrates that the nuclear receptor coactivator AIB1 is a rate-limiting factor for estrogen-dependent growth of human MCF-7 breast cancer cells.

List HJ, Lauritsen KJ, Reiter R, Powers C, Wellstein A, Riegel AT.

J Biol Chem. 2001 Jun 29;276(26):23763-8. Epub 2001 Apr 27.

PMID:
11328819
[PubMed - indexed for MEDLINE]
Free Article
18.

Association of steroid receptor coactivator AIB1 with estrogen receptor-alpha in breast cancer cells.

Azorsa DO, Cunliffe HE, Meltzer PS.

Breast Cancer Res Treat. 2001 Nov;70(2):89-101.

PMID:
11768608
[PubMed - indexed for MEDLINE]
19.

Epidermal growth factor receptor tyrosine phosphorylation and signaling controlled by a nuclear receptor coactivator, amplified in breast cancer 1.

Lahusen T, Fereshteh M, Oh A, Wellstein A, Riegel AT.

Cancer Res. 2007 Aug 1;67(15):7256-65.

PMID:
17671194
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Impact of the nuclear receptor coactivator AIB1 isoform AIB1-Delta3 on estrogenic ligands with different intrinsic activity.

Reiter R, Oh AS, Wellstein A, Riegel AT.

Oncogene. 2004 Jan 15;23(2):403-9.

PMID:
14691461
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk